Recursion Pharmaceuticals OverviewRecursion Pharmaceuticals Net Income
Profitability analysis for RXRX.
Quarterly Net Income
-$117.50M
↑ 41.97% YoY
As of Mar 2026
Annual Net Income (TTM)
-$559.78M
↑ 2.58% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...